标题
Tuberculosis Drug Discovery: A Decade of Hit Assessment for Defined Targets
作者
关键词
-
出版物
Frontiers in Cellular and Infection Microbiology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-03-15
DOI
10.3389/fcimb.2021.611304
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Screening of natural compounds that targets glutamate racemase of Mycobacterium tuberculosis reveals the anti-tubercular potential of flavonoids
- (2020) Alka Pawar et al. Scientific Reports
- Telacebec (Q203), a New Antituberculosis Agent
- (2020) Veronique R. de Jager et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exploring the SAR of the β-Ketoacyl-ACP Synthase Inhibitor GSK3011724A and Optimization around a Genotoxic Metabolite
- (2020) Fraser Cunningham et al. ACS Infectious Diseases
- Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II
- (2019) Wei Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target
- (2019) Bing Zhang et al. CELL
- Advancing the therapeutic potential of indoleamides for tuberculosis
- (2019) Shichun Lun et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development and validation of a multiplex UHPLC-MS/MS method for the determination of the investigational antibiotic against multi-resistant tuberculosis macozinone (PBTZ169) and five active metabolites in human plasma
- (2019) Dany Spaggiari et al. PLoS One
- Inhibiting Mycobacterium tuberculosis DosRST signaling by targeting response regulator DNA binding and sensor kinase heme
- (2019) Huiqing Zheng et al. ACS Chemical Biology
- Inhibition of CorA-Dependent Magnesium Homeostasis Is Cidal in Mycobacterium tuberculosis
- (2019) Yumi Park et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of M. tuberculosis to bedaquiline
- (2019) Zhe Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development
- (2019) Tiago Beites et al. Nature Communications
- Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity
- (2018) Michael B. Harbut et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Drug targets exploited in Mycobacterium tuberculosis : Pitfalls and promises on the horizon
- (2018) Zubair Shanib Bhat et al. BIOMEDICINE & PHARMACOTHERAPY
- Therapeutic potential of promiscuous targets in Mycobacterium tuberculosis
- (2018) Bei Shi Lee et al. CURRENT OPINION IN PHARMACOLOGY
- Identification and development of benzoxazole derivatives as novel bacterial glutamate racemase inhibitors
- (2018) Prasanthi Malapati et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Expanding Benzoxazole-Based Inosine 5′-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure–Activity As Potential Antituberculosis Agents
- (2018) Shibin Chacko et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis
- (2018) Wei Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Morpholino Thiophenes as Novel Mycobacterium tuberculosis Inhibitors, Targeting QcrB
- (2018) Laura A. T. Cleghorn et al. JOURNAL OF MEDICINAL CHEMISTRY
- Plasticity ofMycobacterium tuberculosisNADH dehydrogenases and their role in virulence
- (2018) Catherine Vilchèze et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure–Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization
- (2018) Dinakaran Murugesan et al. ACS Infectious Diseases
- Bedaquiline and delamanid in the treatment of multidrug‐resistant tuberculosis: Promising but challenging
- (2018) Yang Li et al. DRUG DEVELOPMENT RESEARCH
- Easy-To-Synthesize Spirocyclic Compounds Possess Remarkable in Vivo Activity against Mycobacterium tuberculosis
- (2018) Ana Guardia et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and Structure–Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2′-Oxidase
- (2018) Sangmi Oh et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasA
- (2018) Pradeep Kumar et al. mBio
- Structure-Based Optimization of Pyridoxal 5′-Phosphate-Dependent Transaminase Enzyme (BioA) Inhibitors that Target Biotin Biosynthesis in Mycobacterium tuberculosis
- (2017) Feng Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rational Design, Synthesis, and Biological Evaluation of Heterocyclic Quinolones Targeting the Respiratory Chain of Mycobacterium tuberculosis
- (2017) W. David Hong et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Novel Small-Molecule Inhibitor of the Mycobacterium tuberculosis Demethylmenaquinone Methyltransferase MenG Is Bactericidal to Both Growing and Nutritionally Deprived Persister Cells
- (2017) Paridhi Sukheja et al. mBio
- Mtb PKNA/PKNB Dual Inhibition Provides Selectivity Advantages for Inhibitor Design To Minimize Host Kinase Interactions
- (2017) Tiansheng Wang et al. ACS Medicinal Chemistry Letters
- EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide
- (2017) Michelle L. T. Ang et al. Frontiers in Microbiology
- Improved Phenoxyalkylbenzimidazoles with Activity against Mycobacterium tuberculosis Appear to Target QcrB
- (2017) N. Susantha Chandrasekera et al. ACS Infectious Diseases
- Glutamate Racemase Is the Primary Target of β-Chloro-d-Alanine in Mycobacterium tuberculosis
- (2016) Gareth A. Prosser et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3
- (2016) Wei Li et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Exploring the structure of glutamate racemase from Mycobacterium tuberculosis as a template for anti-mycobacterial drug discovery
- (2016) S. Poen et al. BIOCHEMICAL JOURNAL
- Recent advances in the discovery and development of antibacterial agents targeting the cell-division protein FtsZ
- (2016) Krupanandan Haranahalli et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Making a Long Journey Short: Alkyne Functionalization of Natural Product Scaffolds
- (2016) Johannes Lehmann et al. CHEMISTRY-A EUROPEAN JOURNAL
- New and Old Hot Drug Targets in Tuberculosis
- (2016) Laurent Roberto Chiarelli et al. CURRENT MEDICINAL CHEMISTRY
- New direct inhibitors of InhA with antimycobacterial activity based on a tetrahydropyran scaffold
- (2016) Stane Pajk et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inhibitors of the Cysteine Synthase CysM with Antibacterial Potency against Dormant Mycobacterium tuberculosis
- (2016) Katharina Brunner et al. JOURNAL OF MEDICINAL CHEMISTRY
- Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection
- (2016) Jozef Stec et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibitors of Mycobacterium tuberculosis DosRST signaling and persistence
- (2016) Huiqing Zheng et al. Nature Chemical Biology
- Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target
- (2016) KATHERINE A. ABRAHAMS et al. PARASITOLOGY
- Identification of KasA as the cellular target of an anti-tubercular scaffold
- (2016) Katherine A. Abrahams et al. Nature Communications
- Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis
- (2016) Joanna C. Evans et al. ACS Infectious Diseases
- The Inosine Monophosphate Dehydrogenase, GuaB2, Is a Vulnerable New Bactericidal Drug Target for Tuberculosis
- (2016) Vinayak Singh et al. ACS Infectious Diseases
- A Target-Based Whole Cell Screen Approach To Identify Potential Inhibitors of Mycobacterium tuberculosis Signal Peptidase
- (2016) Shilah A. Bonnett et al. ACS Infectious Diseases
- Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis
- (2016) Yumi Park et al. ACS Infectious Diseases
- Target-Based Identification of Whole-Cell Active Inhibitors of Biotin Biosynthesis in Mycobacterium tuberculosis
- (2015) Sae Woong Park et al. CHEMISTRY & BIOLOGY
- Structure activity relationships of 4-hydroxy-2-pyridones: A novel class of antituberculosis agents
- (2015) Pearly Shuyi Ng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Cell division inhibitors with efficacy equivalent to isoniazid in the acute murineMycobacterium tuberculosisinfection model
- (2015) Susan E. Knudson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Identification of Phenoxyalkylbenzimidazoles with Antitubercular Activity
- (2015) N. Susantha Chandrasekera et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds
- (2015) Magdalena Makowska-Grzyska et al. PLoS One
- Direct inhibitors of InhA are active against Mycobacterium tuberculosis
- (2015) U. H. Manjunatha et al. Science Translational Medicine
- 2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1
- (2014) João Neres et al. ACS Chemical Biology
- Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery
- (2014) E Sim et al. BRITISH JOURNAL OF PHARMACOLOGY
- Towards a new combination therapy for tuberculosis with next generation benzothiazinones
- (2014) V. Makarov et al. EMBO Molecular Medicine
- Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent
- (2014) Sunhee Kang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Encoded Library Technology as a Source of Hits for the Discovery and Lead Optimization of a Potent and Selective Class of Bactericidal Direct Inhibitors of Mycobacterium tuberculosis InhA
- (2014) Lourdes Encinas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Evaluation of New Thiadiazole-Based Direct Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) for the Treatment of Tuberculosis
- (2014) Roman Šink et al. JOURNAL OF MEDICINAL CHEMISTRY
- 4-Aminoquinolone Piperidine Amides: Noncovalent Inhibitors of DprE1 with Long Residence Time and Potent Antimycobacterial Activity
- (2014) Maruti Naik et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Pyrazolopyridones as a Novel Class of Noncovalent DprE1 Inhibitor with Potent Anti-Mycobacterial Activity
- (2014) Manoranjan Panda et al. JOURNAL OF MEDICINAL CHEMISTRY
- Future target-based drug discovery for tuberculosis?
- (2014) Bavesh Davandra Kana et al. TUBERCULOSIS
- The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis
- (2013) Giovanna Riccardi et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties
- (2013) E. Jeffrey North et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A medicinal chemists’ guide to the unique difficulties of lead optimization for tuberculosis
- (2013) Véronique Dartois et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
- (2013) Lluís Ballell et al. ChemMedChem
- Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis
- (2013) N. Alsaad et al. EUROPEAN RESPIRATORY JOURNAL
- Structural Basis for the Recognition of Mycolic Acid Precursors by KasA, a Condensing Enzyme and Drug Target fromMycobacterium Tuberculosis
- (2013) Johannes Schiebel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SAR Studies on Trisubstituted Benzimidazoles as Inhibitors of Mtb FtsZ for the Development of Novel Antitubercular Agents
- (2013) Divya Awasthi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Methyl-Thiazoles: A Novel Mode of Inhibition with the Potential to Develop Novel Inhibitors Targeting InhA in Mycobacterium tuberculosis
- (2013) Pravin S. Shirude et al. JOURNAL OF MEDICINAL CHEMISTRY
- Preliminary Structure–Activity Relationships and Biological Evaluation of Novel Antitubercular Indolecarboxamide Derivatives Against Drug-Susceptible and Drug-Resistant Mycobacterium tuberculosis Strains
- (2013) Oluseye K. Onajole et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides: A Promising Class of Antituberculosis Agents
- (2013) Ravinder Reddy Kondreddi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis
- (2013) Regina Wilson et al. Nature Chemical Biology
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- Mycobacterium tuberculosis Rv3406 Is a Type II Alkyl Sulfatase Capable of Sulfate Scavenging
- (2013) Kimberly M. Sogi et al. PLoS One
- Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3
- (2013) Modesto J. Remuiñán et al. PLoS One
- Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis
- (2013) Thomas R. Ioerger et al. PLoS One
- Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis
- (2013) S. P. S. Rao et al. Science Translational Medicine
- Discovery of Tetrahydropyrazolopyrimidine Carboxamide Derivatives As Potent and Orally Active Antitubercular Agents
- (2013) Fumiaki Yokokawa et al. ACS Medicinal Chemistry Letters
- Indoleamides are active against drug-resistant Mycobacterium tuberculosis
- (2013) Shichun Lun et al. Nature Communications
- SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis
- (2012) Kapil Tahlan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability
- (2012) Michael S. Scherman et al. BIOORGANIC & MEDICINAL CHEMISTRY
- MmpL Genes Are Associated with Mycolic Acid Metabolism in Mycobacteria and Corynebacteria
- (2012) Cristian Varela et al. CHEMISTRY & BIOLOGY
- Discovery of Novel N-Phenylphenoxyacetamide Derivatives as EthR Inhibitors and Ethionamide Boosters by Combining High-Throughput Screening and Synthesis
- (2012) Marion Flipo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of mycolic acid transport across the Mycobacterium tuberculosis plasma membrane
- (2012) Anna E Grzegorzewicz et al. Nature Chemical Biology
- Quinolinyl Pyrimidines: Potent Inhibitors of NDH-2 as a Novel Class of Anti-TB Agents
- (2012) Pravin S. Shirude et al. ACS Medicinal Chemistry Letters
- Novel Inhibitors of InhA Efficiently KillMycobacterium tuberculosisunder Aerobic and Anaerobic Conditions
- (2011) Catherine Vilchèze et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The structure–activity relationship of urea derivatives as anti-tuberculosis agents
- (2011) Joshua R. Brown et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Structural Characterization of theMycobacterium tuberculosisBiotin Biosynthesis Enzymes 7,8-Diaminopelargonic Acid Synthase and Dethiobiotin Synthetase,
- (2010) Sanghamitra Dey et al. BIOCHEMISTRY
- Novel Trisubstituted Benzimidazoles, TargetingMtbFtsZ, as a New Class of Antitubercular Agents
- (2010) Kunal Kumar et al. JOURNAL OF MEDICINAL CHEMISTRY
- A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy
- (2010) Kevin Pethe et al. Nature Communications
- Inosine monophosphate dehydrogenase as a target for antiviral, anticancer, antimicrobial and immunosuppressive therapeutics
- (2009) Sonja B Braun-Sand et al. Future Medicinal Chemistry
- Synthetic EthR inhibitors boost antituberculous activity of ethionamide
- (2009) Nicolas Willand et al. NATURE MEDICINE
- Platensimycin Activity against Mycobacterial β-Ketoacyl-ACP Synthases
- (2009) Alistair K. Brown et al. PLoS One
- Antituberculosis activity of the molecular libraries screening center network library
- (2009) Joseph A. Maddry et al. TUBERCULOSIS
- High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv
- (2009) Subramaniam Ananthan et al. TUBERCULOSIS
- The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis
- (2008) S. P. S. Rao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Glutamate racemase as a target for drug discovery
- (2008) Stewart L. Fisher Microbial Biotechnology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now